These Terms of Use ("Terms") constitute a legally binding agreement between you ("Customer," "User," "Subscriber," "Organization," or "you") and iCretegy Solutions Private Limited (part of iPharmaSolutions LLC) (collectively referred to as "iCretegy," "iPharmaAI," "Company," Provider, "we," "our," or "us"), governing your access to and use of the iPharmaAI platform, available through www.ipharmaai.com , together with any affiliated websites, web applications, databases, documentation, content, and related services (collectively, the "Services").
These Terms apply to all individuals and entities accessing or using the Services, including customers, subscribers, organizations, administrators, employees, contractors, consultants, and other authorized users.
iPharmaAI is a platform designed to support pharmaceutical, regulatory, quality, compliance, and inspection readiness teams.
The platform may include:
iPharmaAI may update, improve, modify, or discontinue parts of the platform from time to time. Such features may be included within an existing subscription, offered as optional add-on services, or made available under separate commercial terms.
iPharmaAI provides regulatory intelligence, audit support, checklists, templates, and documentation tools intended solely for professional and lawful business use.
The platform does not replace professional regulatory judgment, legal advice, quality review, scientific assessment, or final decision-making by qualified personnel. Users are responsible for reviewing and validating all information, outputs, templates, and reports before use.
Access is limited to authorized users approved by iPharmaAI or the customer.
iPharmaAI uses a controlled single sign-in access model. Access may be user-specific, browser-specific, and/or system-specific for security purposes. Users may not share login credentials or allow unauthorized access.
Users cannot reset passwords directly through the platform. For password reset, browser change, device change, or access issues, users must contact: icretools@icretegy.com
iPharmaAI may verify the user’s identity, company authorization, browser, device, or account status before restoring access.
Subject to applicable fees and subscription terms, iPharmaAI grants customers a limited, non-exclusive, non-transferable, revocable license to access and use the platform for internal business, regulatory, quality, compliance, audit readiness, and documentation support purposes.
Downloadable checklists, templates, reports, CTD materials, user guides, and other documents may be used only for the customer’s internal business purposes.
Customers and users may not sell, resell, sublicense, publish, distribute, copy, reverse engineer, or commercially exploit the platform, database, templates, checklists, reports, or documentation without written permission from iPharmaAI.
Customer Data means information, documents, files, inputs, comments, business details, regulatory information, or other materials submitted or provided by customers or users.
Customers retain ownership of their Customer Data. iPharmaAI may use Customer Data only as needed to provide services, manage accounts, respond to support requests, improve platform performance, maintain security, troubleshoot issues, and comply with legal or contractual obligations.
iPharmaAI does not sell Customer Data and does not intentionally use customer confidential information to train public AI models unless expressly agreed in writing.
Customers and users are responsible for:
Customers are responsible for all regulatory, quality, business, audit, and submission-related decisions made using the platform.
Users may not:
iPharmaAI may suspend or terminate access if prohibited use is suspected.
Each party may receive confidential business, regulatory, technical, commercial, or platform-related information from the other party.
Both parties agree to protect confidential information using reasonable care and to use it only for purposes allowed under these Terms or applicable written agreements.
Confidential information does not include information that is publicly available, already known without restriction, independently developed, or legally required to be disclosed.
iPharmaAI owns and retains all rights in the platform, software, databases, technology, user interface, workflows, analytics, templates, checklists, reports, documentation, trademarks, logos, methodologies, and related intellectual property.
No ownership rights are transferred to customers or users. Customers receive only the limited access and use rights stated in these Terms.
Feedback or suggestions provided by users may be used by iPharmaAI to improve its products and services without obligation, provided customer confidential information is not improperly disclosed.
Customers agree to pay all fees stated in the applicable proposal, invoice, order form, subscription plan, statement of work, or written agreement. Provider reserves the right to modify its fees upon renewal, with at least thirty (30) days prior written notice.
Unless otherwise agreed in writing, fees are non-refundable, taxes and bank charges or other fee imposed by law or regulation in connection with the services are the customer’s responsibility, and late payment may result in suspension or termination of platform access.
Subscription terms, user limits, pricing, renewals, and payment timelines will be governed by the applicable written agreement or invoice.
These Terms apply while the customer or user accesses the website, platform, or services.
iPharmaAI may suspend or terminate access if:
Upon termination, access may be disabled, user accounts may be deactivated, and the customer must stop using the platform and iPharmaAI materials except as expressly permitted in writing.
Confidentiality, payment obligations, intellectual property rights, limitations of liability, and other provisions intended to survive termination will continue to apply.
EXCEPT FOR ANY WARRANTIES THAT CANNOT BE EXCLUDED OR LIMITED UNDER APPLICABLE LAW, THE SERVICES (INCLUDING CONTENT AND LICENSED WORKS) ARE PROVIDED SOLELY ON AN “AS IS” AND “AS AVAILABLE” BASIS AND WE DO NOT GUARANTEE THAT THE SERVICES WILL BE UNINTERRUPTED OR THAT THEY ARE ERROR FREE. WE DISCLAIM ALL EXPRESS, IMPLIED OR STATUTORY WARRANTIES AND REPRESENTATIONS INCLUDING THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY OF DATA, AND NONINFRINGEMENT.
TO THE MAXIMUM EXTENT PERMITTED BY LAW, PROVIDER WILL NOT BE LIABLE FOR INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, PUNITIVE, OR SIMILAR DAMAGES, INCLUDING LOSS OF PROFITS, LOSS OF REVENUE, LOSS OF BUSINESS OPPORTUNITY, LOSS OF DATA, REGULATORY DELAYS, INSPECTION OUTCOMES, SUBMISSION DEFICIENCIES, ENFORCEMENT ACTIONS, OR BUSINESS INTERRUPTION.
TO THE MAXIMUM EXTENT PERMITTED BY LAW, PROVIDER TOTAL LIABILITY WILL NOT EXCEED THE AMOUNT PAID BY THE CUSTOMER TO PROVIDER FOR THE APPLICABLE SERVICE DURING THE TWELVE MONTHS BEFORE THE CLAIM AROSE.
The customer agrees to defend, indemnify, and hold harmless iPharmaAI, its owners, officers, employees, contractors, affiliates, licensors, and service providers from claims, damages, losses, costs, and expenses arising from:
Use of iPharmaAI is also governed by our Privacy Policy, which explains how we collect, use, protect, and disclose information.
By using the platform, users acknowledge that they have reviewed the Privacy Policy.
iPharmaAI may update these Terms from time to time. Updated Terms will be posted on the website or otherwise made available.
Continued use of the website or platform after updates means the customer and users accept the updated Terms.
These Terms will be governed by the laws stated in the applicable order form, proposal, invoice, subscription agreement, or written contract.
If no governing law is stated, the governing law will be determined based on the principal business location of iPharmaAI , unless otherwise required by applicable law.
If you have any questions about these Terms of Service, please contact us:
iPharmaAI / iCretegy
Email: icretools@icretegy.com
Company: iCretegy Solutions Private Limited (a part of iPharmaSolutions LLC)